SCHEMBL5457840

SCHEMBL5457840

CC(C)(C)OC(=O)N1CCN(c2ccc(NC(=O)Nc3ccccc3F)cc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.62
MAPT P10636 6/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TSHR P16473 1/20 0.54
NPC1 O15118 6/20 0.52
HTT P42858 4/20 0.52
ALDH1A1 P00352 3/20 0.52
LMNA P02545 2/20 0.52
ESR2 Q92731 1/20 0.52
NR2F2 P24468 1/20 0.52
RAB9A P51151 5/20 0.51
NFKB1 P19838 2/20 0.51
NFKB2 Q00653 2/20 0.51
RELA Q04206 2/20 0.51
GPR119 Q8TDV5 2/20 0.51
PKM P14618 1/20 0.51
CCNK O75909 1/20 0.50
CCNA2 P20248 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5457972 0.88 NAMPT (0.64) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5459771 0.88 NPY2R (0.52) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5464907 0.87 NAMPT (0.62) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5465659 0.87 NAMPT (0.54) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5460804 0.86 MAPT (0.68) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5458425 0.86 NAMPT (0.61) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5458260 0.86 NAMPT (0.61) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5465589 0.86 NAMPT (0.58) NAMPTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5465646 0.86 NPY2R (0.57) MAPTSMN1; SMN2MEN1KMT2ANPC1
SCHEMBL5460905 0.85 NAMPT (0.57) NAMPTMAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885MAPT 758/4885SMN1; SMN2 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.